OPK – OPKO Health, Inc.

Opko Health, Inc.

OPK

$1.38

Name : Opko Health, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $1,095,420,288.00

EPSttm : -0.24

Opko Health, Inc.

$1.38

0.72%

$0.01

Float Short %

8.02

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.11

EPS Last/This Y

-0.25

EPS This/Next Y

0.02

Price

1.38

Target Price

3.56

Analyst Recom

1.57

Performance Q

Relative Volume

1.13

Beta

1.38

Ticker: OPK

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	OPK	1.28	0.07	0.00	55780
2025-11-14	OPK	1.285	0.07	0.00	56434
2025-11-17	OPK	1.275	0.06	0.04	57688
2025-11-18	OPK	1.28	0.06	0.02	58542
2025-11-19	OPK	1.31	0.06	0.07	59038
2025-11-20	OPK	1.29	0.06	0.05	58876
2025-11-21	OPK	1.32	0.06	0.21	59101
2025-11-24	OPK	1.305	0.06	0.07	57133
2025-11-25	OPK	1.345	0.06	0.07	57896
2025-11-26	OPK	1.345	0.06	0.19	58227
2025-12-01	OPK	1.325	0.06	3.10	58383
2025-12-02	OPK	1.335	0.06	0.22	58471
2025-12-03	OPK	1.365	0.06	1.93	58462
2025-12-04	OPK	1.355	0.05	2.08	58360
2025-12-05	OPK	1.345	0.05	0.06	58372
2025-12-08	OPK	1.325	0.05	0.10	58404
2025-12-09	OPK	1.35	0.05	0.02	58517
2025-12-10	OPK	1.38	0.05	0.09	58746
2025-12-11	OPK	1.385	0.05	0.08	58829
2025-12-12	OPK	1.385	0.05	0.24	58890
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	OPK	1.28	-	-	-0.32
2025-11-14	OPK	1.28	-	-	-0.32
2025-11-17	OPK	1.27	-	-	-0.32
2025-11-18	OPK	1.28	-	-	-0.32
2025-11-19	OPK	1.31	-	-	-0.32
2025-11-20	OPK	1.29	-	-	-0.32
2025-11-21	OPK	1.33	-	-	-0.32
2025-11-24	OPK	1.30	-	-	-0.32
2025-11-25	OPK	1.35	-	-	-0.33
2025-11-26	OPK	1.35	-	-	-0.33
2025-12-01	OPK	1.32	-	-	-0.33
2025-12-02	OPK	1.33	-	-	-0.33
2025-12-03	OPK	1.37	-	-	-0.33
2025-12-04	OPK	1.36	-	-	-0.33
2025-12-05	OPK	1.34	-	-	-0.33
2025-12-08	OPK	1.32	-	-	-0.33
2025-12-09	OPK	1.36	-	-	-0.33
2025-12-10	OPK	1.38	-	-	-0.33
2025-12-11	OPK	1.38	-	-	-0.33
2025-12-12	OPK	1.38	-	-	-0.33
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	OPK	0.22	-8.97	8.31
2025-11-14	OPK	0.22	-8.97	8.31
2025-11-17	OPK	0.22	-2.32	8.31
2025-11-18	OPK	0.22	-2.32	8.31
2025-11-19	OPK	0.52	-2.32	8.31
2025-11-20	OPK	0.52	-2.32	8.31
2025-11-21	OPK	0.68	-2.32	8.31
2025-11-24	OPK	0.84	0.43	8.32
2025-11-25	OPK	0.83	0.43	8.35
2025-11-26	OPK	0.83	0.43	8.62
2025-12-01	OPK	0.83	-2.99	8.63
2025-12-02	OPK	0.83	-2.99	8.63
2025-12-03	OPK	0.83	-2.99	8.63
2025-12-04	OPK	0.83	-2.99	8.63
2025-12-05	OPK	0.83	-2.99	8.63
2025-12-08	OPK	0.83	-3.00	8.63
2025-12-09	OPK	0.83	-3.00	8.63
2025-12-10	OPK	0.83	-3.00	8.02
2025-12-11	OPK	0.83	-3.00	8.02
2025-12-12	OPK	0.83	-3.00	8.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="OPK" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.03

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

0.83

Institutional Transactions

-3

Beta

1.38

Average Sales Estimate Current Quarter

139

Average Sales Estimate Next Quarter

130

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-85.6

Target Price

3.56

P/E

Forward P/E

PEG

P/S

1.65

P/B

0.81

P/Free Cash Flow

EPS

-0.25

Average EPS Est. Cur. Y

-0.33

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-28.1

Relative Volume

1.13

Return on Equity vs Sector %

-40.7

Return on Equity vs Industry %

-24.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”OPK” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”OPK” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”OPK” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”OPK” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”OPK” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”OPK” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”OPK” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Opko Health, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2997

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, immunology, and infectious diseases; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins or peptides; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products for a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Spain, Ireland, Chile, and Mexico. OPKO Health, Inc. was founded in 2007 and is headquartered in Miami, Florida.

stock quote shares OPK – OPKO Health, Inc. Stock Price stock today

news today OPK – OPKO Health, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch OPK – OPKO Health, Inc. yahoo finance google finance

stock history OPK – OPKO Health, Inc. invest stock market

stock prices OPK premarket after hours

ticker OPK fair value insiders trading

OPK – OPKO Health, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: OPK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y